Medicxi Ventures Management (Jersey) Ltd
Top Portfolio Positions
4 positions ·
$981,805,432 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
19,963,157 | $792,936,596 | 80.76% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
2,674,182 | $85,600,565 | 8.72% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
7,464,572 | $82,931,394 | 8.45% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
3,039,892 | $20,336,877 | 2.07% |
Portfolio Trend
25 quarters · across all stocks
Holdings in NAMS
Shares Held
Position Value (USD)
14 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $85,600,565 | 2,674,182 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $100,664,340 | 2,869,565 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $81,610,428 | 2,869,565 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $51,967,822 | 2,869,565 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $58,739,995 | 2,869,565 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $73,747,820 | 2,869,565 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $47,634,779 | 2,869,565 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $55,124,343 | 2,869,565 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $67,865,212 | 2,869,565 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $32,053,041 | 2,869,565 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $26,543,476 | 2,869,565 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $34,119,127 | 2,869,565 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $26,520,000 | 2,000,000 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $21,800,000 | 2,000,000 | Shares | Sole | 2023-01-31 | |
| No 13F history on record for this holder in this stock. | ||||||